OM
Outset Medical Inc.
Company Overview
| Mkt Cap | $257.08M | Price | $4.69 |
| Volume | 192.88K | Change | +8.56% |
| P/E Ratio | -3.1 | Open | $4.48 |
| Revenue | $119.5M | Prev Close | $4.32 |
| Net Income | $-81.7M | 52W Range | $3.00 - $21.98 |
| Div Yield | N/A | Target | $7.67 |
| Overall | 55 | Value | 60 |
| Quality | 55 | Technical | 50 |
No chart data available
About Outset Medical Inc.
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Latest News
Palantir Shareholders Back Management, Reject ESG Proposals
Verrica Shareholders Approve Governance Measures at Annual Meeting
LB Pharmaceuticals Stockholders Approve Directors and Auditor
Medalist Diversified REIT Announces New Kansas Property Acquisition
Offerpad Implements Reverse Stock Split Following Shareholder Approval
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OM | $4.69 | +8.6% | 192.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |